NGS Service—Illumina Sequencing Technology

The main reason for using next-generation sequencing is the effective reduction in turnaround time with NGS compared to traditional methods. At the same time, next-generation sequencing makes it possible to analyze the transcriptome and genome of a species in a detailed and holistic way. CD Genomics offers a growing range of services, from library construction to sequencing to complete experimental design and support. Our Illumina Sequencing Technology-based next-generation sequencing technology can help you advance genome engineering innovation.

Name of the Instrument/Technicial Service

Illumina Sequencing Technology

Summary

We host robust next generation sequencing systems from Illumina. A variety of (multiplexed) assays is established, e.g.: RNA seq, DNA seq, Exome Seq for intact and low quality DNA and targeted resequencing. Currently the following machine are in use:
Our NextSeq 1000 generates up to 500 Mio reads on a single lane with 100, 200 or 300 bases per run, enabling up to 2×150bp paired-end sequencing. Read lengths can be apapted to the need of the individual projects, e.g. 2×60 for ChIP seq and ATACseq or 28+8+8+91 for scRNA seq. The NextSeq 1000 was partially funded by the Excellence Cluster ORIGINS.
Our NextSeq 2000 can generate up to 1400 million reads on a single lane. It handles P3 flowcells that allow a fast processing of larger sequencing projects and offer very cost efficient runs with short single-end reads. The NextSeq 2000 was partially funded by the Bay-VOC project.

CD Genomics, as a specialist sequencing company, has a large range of sequencers in our NGS Core, including Illumina MiSeq, NovaSeq, PacBio, and more. If you require this service, please contact us directly.

Online Inquiry

Please fill out the form below and we will get back to you as soon as possible with a quotation for the item you are interested in.